相关实验视频

Updated: May 5, 2026

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

塞尔-CS1K:一种塞拉斯特罗-基托桑结合物,用于治疗饮食引起的肥胖症

Huahui Zeng¹, Qikang Tian¹, Can Wang²

¹Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou 450046, China.

Chemical research in toxicology

|May 21, 2024

概括

塞拉斯特罗尔-奇托桑结合物 (Cel-CS1K) 为治疗肥胖提供了一个更安全,更有效的策略. 这种新型化合物可以降低体重和脂肪积累,毒性明显低于单独的塞拉斯特.

科学领域:

药理学药理学是指药理学的学科.
生物材料科学生物材料科学
代谢疾病代谢疾病

背景情况:

塞拉斯 (Cel) 显示出抗肥胖的潜力,但具有临床不良反应.
开发更安全的Cel输送系统对于治疗应用至关重要.

研究的目的:

合成和描述一个切拉斯特罗尔-奇托桑结合物 (Cel-CS1K).
评估Cel-CS1K在饮食诱导的肥胖小鼠中的抗肥胖疗效和生物安全性.

主要方法:

合成Cel-CS1K,具有较高的药物负载和良好的溶解性.
在老鼠中进行的药理动力学研究 (Tmax,T1/2).
细胞毒性和肝细胞效应的体外评估.
在饮食诱导的肥胖小鼠体内评估,包括体重,饮食摄入量,血液参数和基因表达分析.

主要成果:

细胞-CS1K显示出有利的药理动力学和减弱肝细胞损伤.
与自由细胞相比,Cel-CS1K有效降低了体重和饮食摄入量,降低了血液,肝脏和丸中的毒性.
观察到改善的葡萄糖平衡,高密度胆固醇,胰岛素敏感性和瘦素敏感性.
细胞-CS1K调节脂肪相关基因表达,支持其减肥机制.

结论:

塞尔-CS1K是一种对肥胖的有前途的治疗策略,提供了更好的疗效和安全性.
结合剂显示出治疗人类饮食引起的肥胖症的潜力.

更多相关视频

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

相关概念视频

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...